Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/878
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Mirtazapine (Tablet, Orally Disintegrating)
|
| dailymed-instance:dosage |
Initial Treatment:<br/>Administration of Mirtazapine Orally Disintegrating Tablets:<br/>Elderly and Patients with Renal or Hepatic Impairment:<br/>Maintenance/Extended Treatment:<br/>Switching Patients To or From a Monoamine Oxidase Inhibitor:
|
| dailymed-instance:clinicalP... |
Pharmacodynamics:<br/>Pharmacokinetics:<br/>Special Populations:<br/>Geriatric:<br/>Pediatrics:<br/>Gender:<br/>Race:<br/>Renal Insufficiency:<br/>Hepatic Insufficiency:<br/>Clinical Trials Showing Effectiveness:
|
| dailymed-instance:activeIng... | |
| dailymed-instance:genericDr... | |
| dailymed-instance:boxedWarn... |
BOXED WARNING:
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... |
dailymed-ingredient:Aspartame,
dailymed-ingredient:Colloidal_Silicon_Dioxide,
dailymed-ingredient:Crospovidone,
dailymed-ingredient:Magnesium_Stearate,
dailymed-ingredient:Mannitol,
dailymed-ingredient:Microcrystalline_Cellulose,
dailymed-ingredient:Natural_and_Artificial_Peppermint_Flavor,
dailymed-ingredient:Strawberry_Guarana_Flavor
|
| dailymed-instance:possibleD... | |
| dailymed-instance:precautio... |
General:<br/>Somnolence:<br/>Dizziness:<br/>Increased Appetite/Weight Gain:<br/>Cholesterol/Triglycerides:<br/>Transaminase Elevations:<br/>Activation of Mania/Hypomania:<br/>Seizure:<br/>Use in Patients with Concomitant Illness:<br/>Information for Patients:<br/>Clinical Worsening and Suicide Risk:<br/>Agranulocytosis:<br/>Interference with Cognitive and Motor Performance:<br/>Completing Course of Therapy:<br/>Concomitant Medication:<br/>Alcohol:<br/>Phenylketonurics:<br/>Pregnancy:<br/>Nursing:<br/>Laboratory Tests:<br/>Drug Interactions:<br/>Drugs Affecting Hepatic Metabolism:<br/>Drugs that are Metabolized by and/or Inhibit Cytochrome P450 Enzymes:<br/>Alcohol:<br/>Diazepam:<br/>Carcinogenesis, Mutagenesis, Impairment of Fertility:<br/>Carcinogenesis:<br/>Mutagenesis:<br/>Impairment of Fertility:<br/>Pregnancy:<br/>Teratogenic effects:<br/>Nursing Mothers:<br/>Pediatric Use:<br/>Geriatric Use:
|
| dailymed-instance:overdosag... |
Human Experience:<br/>Overdose Management:
|
| dailymed-instance:genericMe... |
Mirtazapine
|
| dailymed-instance:fullName |
Mirtazapine (Tablet, Orally Disintegrating)
|
| dailymed-instance:adverseRe... |
Associated with Discontinuation of Treatment:<br/>Commonly Observed Adverse Events in US Controlled Clinical Trials:<br/>Adverse Events Occurring at an Incidence of 1% or More Among Mirtazapine-Treated Patients:<br/>ECG Changes:<br/>Other Adverse Events Observed During the Premarketing Evaluation of Mirtazapine:<br/>Other Adverse Events Observed During Postmarketing Evaluation of Mirtazapine:
|
| dailymed-instance:warning |
Clinical Worsening and Suicide Risk:<br/>Screening Patients for Bipolar Disorder:<br/>Agranulocytosis:<br/>MAO Inhibitors:
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Mirtazapine
|